Last updated 10 days ago
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
2500 patients around the world
Available in Spain, Peru, Brazil, Argentina, United States
AstraZeneca
1Research sites
2500Patients around the world
This study is for people with
Renal disease
Chronic kidney disease
Arterial hypertension
Requirements for the patient
To 130 Years
All Gender
Medical requirements
SponsorAstraZeneca
Conditions
Chronic kidney disease
Requirements
To 130 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06268873
